Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 26249
Gene Symbol: KLHL3
KLHL3
0.500 CausalMutation disease CLINVAR
Entrez Id: 4306
Gene Symbol: NR3C2
NR3C2
0.310 Biomarker disease CTD_human
Entrez Id: 8675
Gene Symbol: STX16
STX16
0.300 Biomarker disease CTD_human
Entrez Id: 149775
Gene Symbol: GNAS-AS1
GNAS-AS1
0.300 Biomarker disease CTD_human
Entrez Id: 2778
Gene Symbol: GNAS
GNAS
0.300 Biomarker disease CTD_human
Entrez Id: 6338
Gene Symbol: SCNN1B
SCNN1B
0.300 Biomarker disease CTD_human
Entrez Id: 8452
Gene Symbol: CUL3
CUL3
0.200 CausalMutation disease CLINVAR
Entrez Id: 5972
Gene Symbol: REN
REN
0.050 GeneticVariation disease BEFREE 1.Familial hyperkalaemic hypertension (FHH), also called pseudohypoaldosteronism type II (PHA2) or Gordon syndrome, is a rare Mendelian-form of low-renin hypertension. 11903313 2001
Entrez Id: 5972
Gene Symbol: REN
REN
0.050 Biomarker disease BEFREE 1.In Gordon's syndrome (GS; a syndrome of hypertension and hyperkalaemia with normal glomerular filtration rate), excessive proximal sodium reabsorption leads to suppression of renin and aldosterone, hyperkalaemia and hyperchloraemic acidosis.2. 2065475 1991
Entrez Id: 5972
Gene Symbol: REN
REN
0.050 GeneticVariation disease BEFREE Pseudohypoaldosteronism type II (PHA2) is a rare autosomal dominant form of volume-dependent low-renin hypertension characterized by hyperkalemia and hyperchloremic acidosis but also by a normal glomerular filtration rate. 10869238 2000
Entrez Id: 5972
Gene Symbol: REN
REN
0.050 GeneticVariation disease BEFREE Gordon syndrome (GS) is a rare form of monogenic hypertension characterized by low renin hypertension, hyperkalemia, hyperchloremic metabolic acidosis, and normal glomerular filtration rate. 28222034 2017
Entrez Id: 5972
Gene Symbol: REN
REN
0.050 Biomarker disease BEFREE Pseudohypoaldosteronism type II (PHAII) is a genetic disease characterized by association of hyperkalemia, hyperchloremic metabolic acidosis, hypertension, low renin, and high sensitivity to thiazide diuretics. 30146013 2018
Entrez Id: 65266
Gene Symbol: WNK4
WNK4
0.400 Biomarker disease BEFREE Wnk4, a gene previously identified to cause pseudohypoaldosteronism type II, a rare mendelian form of arterial hypertension, is located on human chromosome 17. 12642508 2003
Entrez Id: 65125
Gene Symbol: WNK1
WNK1
0.400 GeneticVariation disease BEFREE WNK1 mutations have previously been reported to cause pseudohypoaldosteronism type II but have not been studied in the nervous system. 18521183 2008
Entrez Id: 8452
Gene Symbol: CUL3
CUL3
0.200 GeneticVariation disease BEFREE Cullin-3 (<i>CUL3</i>) mutations (<i>CUL3</i>Δ<i>9</i>) were previously identified in hypertensive patients with pseudohypoaldosteronism type-II (PHAII), but the mechanism causing hypertension and whether this is driven by renal tubular or extratubular mechanisms remains unknown. 27882355 2016
Entrez Id: 65266
Gene Symbol: WNK4
WNK4
0.400 Biomarker disease BEFREE WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3. 28743496 2017
Entrez Id: 65266
Gene Symbol: WNK4
WNK4
0.400 GeneticVariation disease BEFREE D564N mutation in WNK4 is a novel genetic cause of PHA2 with a relatively mild phenotype. 31044551 2019
Entrez Id: 65266
Gene Symbol: WNK4
WNK4
0.400 GeneticVariation disease BEFREE A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. 15998707 2005
Entrez Id: 6340
Gene Symbol: SCNN1G
SCNN1G
0.300 Biomarker disease CTD_human A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. 8640238 1996
Entrez Id: 8452
Gene Symbol: CUL3
CUL3
0.200 GeneticVariation disease BEFREE A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3. 23902721 2013
Entrez Id: 26249
Gene Symbol: KLHL3
KLHL3
0.500 GeneticVariation disease BEFREE All patients presented with typical clinical features of GS and had a known dominant KLHL3 mutation. 28222034 2017
Entrez Id: 6559
Gene Symbol: SLC12A3
SLC12A3
0.100 Biomarker disease BEFREE As particularly small doses of thiazide diuretics, inhibitors of NCC activity, correct both the blood pressure and metabolic disorders in PHA2 patients, it was believed that increased NCC was directly responsible for all PHA2 features. 22080857 2012
Entrez Id: 6337
Gene Symbol: SCNN1A
SCNN1A
0.300 Biomarker disease CTD_human Association of a sodium channel alpha subunit promoter variant with blood pressure. 11752024 2002
Entrez Id: 26249
Gene Symbol: KLHL3
KLHL3
0.500 GeneticVariation disease BEFREE By MS and coimmunoprecipitation, we show that KLHL3 normally binds to WNK1 and WNK4, members of WNK (with no lysine) kinase family that have previously been found mutated in PHAII. 23576762 2013
Entrez Id: 65125
Gene Symbol: WNK1
WNK1
0.400 GeneticVariation disease BEFREE By MS and coimmunoprecipitation, we show that KLHL3 normally binds to WNK1 and WNK4, members of WNK (with no lysine) kinase family that have previously been found mutated in PHAII. 23576762 2013